“…It is necessary to emphasize that the vast majority of patients with A‐IAB have at the same time a CHA 2 DS 2 ‐VASc score ≥2 and therefore, if AF is documented, the patients would fulfil conventional indications for oral anticoagulation. Consequently, one could argue that given the association of A‐IAB with AF, there is a possibility that many strokes would be avoided if patients with high CHA 2 DS 2 ‐VASc score and A‐IAB, were treated with anticoagulation regardless of the documented evidence of AF (Chhabra & Gowdar, ; Hughes & Worrall, ; Martínez‐Sellés, Fernández Lozano, Baranchuk, Bayes‐Genis, & Bayés de Luna, ). Of course, the possible benefits derived from this hypothesis; need to be counter balanced with the possible side effects of anticoagulation.…”